PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
01-Sep-2022 EpiEndo Commences LPS Challenge Trial for Lead Candidate EP395 EpiEndo Pharmaceuticals
31-Aug-2022 RECORDATI RARE DISEASES ANNOUNCE PUBLICATION OF LONG-TERM OUTCOMES FROM THE EXTENSION TO THE PHASE III LINC 3 STUDY OF ISTURISA® (OSILODROSTAT) IN PATIENTS WITH CUSHING’S DISEASE IN THE EUROPEAN JOURNAL OF ENDOCRINOLOGY Recordati Rare Diseases
30-Aug-2022 Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio AcuraBio / Ampersand Capital Partners
30-Aug-2022 Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints
30-Aug-2022 Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients Kinarus Therapeutics
29-Aug-2022 Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022 Avance Clinical
26-Aug-2022 Pharma Contract Sales market set to grow at a CAGR of 5.8% by 2031: Visiongain Reports Ltd Visiongain Reports Limited
26-Aug-2022 Black participants represented only 3% of cancer clinical trial participants between 2013 and 2022, finds GlobalData GlobalData
26-Aug-2022 Jazz Pharmaceuticals Announces Initiation of Phase 3 Trial Evaluating Epidiolex®/Epidyolex® (cannabidiol) for Patients with Epilepsy with Myoclonic-Atonic Seizures Jazz Pharmaceuticals
25-Aug-2022 Developments in Gene Therapy for Ocular Diseases SAE Media Group
23-Aug-2022 HUTCHMED Highlights Fruquintinib MRCT FRESCO-2 Data to be Presented at the Upcoming ESMO Congress 2022 HUTCHMED
23-Aug-2022 Global Epilepsy Therapeutics Market worth US$16.6 billion by 2031: Visiongain Reports Ltd Visiongain Reports Limited
23-Aug-2022 Santhera and ReveraGen Announce First Participant Dosed in FDA-funded Phase 2 Pilot Study with Vamorolone in Becker Muscular Dystrophy Santhera
23-Aug-2022 Global Fill Finish Manufacturing Market is projected to grow at a CAGR of 9.0% By 2031: Visiongain Reports Ltd Visiongain Reports Limited
18-Aug-2022 NEW CLINICAL TRIALS INITIATIVE LAUNCHED TO SUPPORT MEDTECH COMPANIES Empact Ventures
16-Aug-2022 Pneumagen Announces First Patient Dosed in Phase 2 Proof of Concept Influenza Challenge Study Assessing Neumifil, an Intranasal Broad-Spectrum Antiviral Pneumagen
15-Aug-2022 R&G Pharmastudies Listed on the ChiNext Market Successfully Legend Capital
12-Aug-2022 Point of Care Diagnostic Market Worth $73,293 Million by 2031: Visiongain Reports Ltd Visiongain Reports Limited
11-Aug-2022 Aqilion starts Phase 1 clinical trial with drug candidate AQ280 for chronic inflammatory diseases AQILION AB
10-Aug-2022 Global CNS Therapeutics Market Forecast is expected to reach US$ 133.2 billion in 2026 Visiongain Reports Limited